Mirum Pharmaceuticals, Inc. Common Stock (MIRM) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRM trades at $96.95 with a market cap of $5.82B and a P/E ratio of -7.07. MIRM moved +1.44% today. Year to date, MIRM is +28.31%; over the trailing twelve months it is +113.83%. Its 52-week range spans $36.88 to $114.99. Analyst consensus is strong buy with an average price target of $146.00. Rallies surfaces MIRM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes MIRM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $96.95 |
| Market Cap | $5.82B |
| P/E Ratio | -7.07 |
| EPS | $-13.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $114.99 |
| 52-Week Low | $36.88 |
| Volume | 462 |
| Avg Volume | 0 |
| Revenue (TTM) | $569.61M |
| Net Income | $-798.84M |
| Gross Margin | 0.00% |
11 analysts cover MIRM: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $146.00.